Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan

In an open observational prospective comparative study based on the National Center for Maternal and Child Health (Department of Pathology of Newborns and Premature Infants) Kyrgyzstan included 103 newborn children with a confirmed diagnosis of intrauterine infections of various etiologies, randomiz...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Alymkulova, A. T. Romanova, S. T. Abduvalieva, N. F. Gagloeva, T. P. Guseva
Format: Article
Language:Russian
Published: Open Systems Publication 2023-02-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/1018
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850065312864534528
author E. M. Alymkulova
A. T. Romanova
S. T. Abduvalieva
N. F. Gagloeva
T. P. Guseva
author_facet E. M. Alymkulova
A. T. Romanova
S. T. Abduvalieva
N. F. Gagloeva
T. P. Guseva
author_sort E. M. Alymkulova
collection DOAJ
description In an open observational prospective comparative study based on the National Center for Maternal and Child Health (Department of Pathology of Newborns and Premature Infants) Kyrgyzstan included 103 newborn children with a confirmed diagnosis of intrauterine infections of various etiologies, randomized into two groups: the main group – 54 children receiving standard therapy (antibacterial, antifungal, symptomatic) in combination with interferon alpha-2b with antioxidants in the dosage form of rectal suppositories (150,000 IU); the comparison group consisted of 49 newborns who received only standard therapy. There was a significant improvement in the general condition of children, which was assessed based on the positive dynamics of the main clinical symptoms of the disease against the background of interferon therapy compared with the comparison group, as well as an increase in the physical development of newborns. Statistically significant positive dynamics of laboratory parameters in the main group compared with the comparison group was determined: a decrease in leukocytosis, neutrophil intoxication index, procalcitonin and lactate levels, leukocyturia and bacteriuria (p < 0.05). There was an increase in the level of serum IFN, the ability of cells to produce both IFN-α and IFN-γ by immunocompetent cells, an increase in the phagocytic function of neutrophils (an increase in phagocytosis from 42% to 51%, phagocytic index from 2.1 ± 0.1 to 3.4 ± 0.2, absolute phagocytic index from 5462 ± 1136 to 10845 ± 1127, a decrease in percent of immature forms of neutrophils from 17.5 ± 2.3 to 7.8 ± 1.2). The use of drugs of recombinant interferon alfa-2b in the early neonatal period led to normalization of the number of lymphocytes, the number of activated cytotoxic T-lymphocytes (5.7 ± 0.9), normalization of immunoglobulin indices of the main classes. No deaths have been recorded. The complete absence of adverse events during the research period and unmotivated refusals of mothers from therapy proved the high tolerability and safety of this drug. The results obtained make it possible to recommend the inclusion of IFN-a2b preparations with antioxidants (rectal suppositories 150,000 IU) in standard treatment regimens for intrauterine infections in full-term and premature infants.
format Article
id doaj-art-b63a9ff5968d4ccc87b1fcb32096a1ea
institution DOAJ
issn 1560-5175
2687-1181
language Russian
publishDate 2023-02-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-b63a9ff5968d4ccc87b1fcb32096a1ea2025-08-20T02:49:02ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812023-02-0101212710.51793/OS.2023.26.1.0041013Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of KyrgyzstanE. M. Alymkulova0A. T. Romanova1S. T. Abduvalieva2N. F. Gagloeva3T. P. Guseva4National Center for Maternal and Child Health of the Ministry of Health of the Republic of KyrgyzstanNational Center for Maternal and Child Health of the Ministry of Health of the Republic of KyrgyzstanNational Center for Maternal and Child Health of the Ministry of Health of the Republic of KyrgyzstanNational Center for Maternal and Child Health of the Ministry of Health of the Republic of KyrgyzstanFederal State Budgetary Institution Gamaleya National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian FederationIn an open observational prospective comparative study based on the National Center for Maternal and Child Health (Department of Pathology of Newborns and Premature Infants) Kyrgyzstan included 103 newborn children with a confirmed diagnosis of intrauterine infections of various etiologies, randomized into two groups: the main group – 54 children receiving standard therapy (antibacterial, antifungal, symptomatic) in combination with interferon alpha-2b with antioxidants in the dosage form of rectal suppositories (150,000 IU); the comparison group consisted of 49 newborns who received only standard therapy. There was a significant improvement in the general condition of children, which was assessed based on the positive dynamics of the main clinical symptoms of the disease against the background of interferon therapy compared with the comparison group, as well as an increase in the physical development of newborns. Statistically significant positive dynamics of laboratory parameters in the main group compared with the comparison group was determined: a decrease in leukocytosis, neutrophil intoxication index, procalcitonin and lactate levels, leukocyturia and bacteriuria (p < 0.05). There was an increase in the level of serum IFN, the ability of cells to produce both IFN-α and IFN-γ by immunocompetent cells, an increase in the phagocytic function of neutrophils (an increase in phagocytosis from 42% to 51%, phagocytic index from 2.1 ± 0.1 to 3.4 ± 0.2, absolute phagocytic index from 5462 ± 1136 to 10845 ± 1127, a decrease in percent of immature forms of neutrophils from 17.5 ± 2.3 to 7.8 ± 1.2). The use of drugs of recombinant interferon alfa-2b in the early neonatal period led to normalization of the number of lymphocytes, the number of activated cytotoxic T-lymphocytes (5.7 ± 0.9), normalization of immunoglobulin indices of the main classes. No deaths have been recorded. The complete absence of adverse events during the research period and unmotivated refusals of mothers from therapy proved the high tolerability and safety of this drug. The results obtained make it possible to recommend the inclusion of IFN-a2b preparations with antioxidants (rectal suppositories 150,000 IU) in standard treatment regimens for intrauterine infections in full-term and premature infants.https://journal.lvrach.ru/jour/article/view/1018intrauterine infectionsinterferon alpha-2b with antioxidantstreatment efficacytolerability and safety
spellingShingle E. M. Alymkulova
A. T. Romanova
S. T. Abduvalieva
N. F. Gagloeva
T. P. Guseva
Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan
Лечащий Врач
intrauterine infections
interferon alpha-2b with antioxidants
treatment efficacy
tolerability and safety
title Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan
title_full Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan
title_fullStr Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan
title_full_unstemmed Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan
title_short Treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa-2b in the Republic of Kyrgyzstan
title_sort treatment of intrauterine infection of viral and bacterial etiology in newborns with drugs of recombinant interferon alfa 2b in the republic of kyrgyzstan
topic intrauterine infections
interferon alpha-2b with antioxidants
treatment efficacy
tolerability and safety
url https://journal.lvrach.ru/jour/article/view/1018
work_keys_str_mv AT emalymkulova treatmentofintrauterineinfectionofviralandbacterialetiologyinnewbornswithdrugsofrecombinantinterferonalfa2bintherepublicofkyrgyzstan
AT atromanova treatmentofintrauterineinfectionofviralandbacterialetiologyinnewbornswithdrugsofrecombinantinterferonalfa2bintherepublicofkyrgyzstan
AT stabduvalieva treatmentofintrauterineinfectionofviralandbacterialetiologyinnewbornswithdrugsofrecombinantinterferonalfa2bintherepublicofkyrgyzstan
AT nfgagloeva treatmentofintrauterineinfectionofviralandbacterialetiologyinnewbornswithdrugsofrecombinantinterferonalfa2bintherepublicofkyrgyzstan
AT tpguseva treatmentofintrauterineinfectionofviralandbacterialetiologyinnewbornswithdrugsofrecombinantinterferonalfa2bintherepublicofkyrgyzstan